KCa3.1 Ion Channel: A Novel Therapeutic Target for Corneal Fibrosis

PLoS ONE - United States
doi 10.1371/journal.pone.0192145
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Αvβ1 Integrin as a Novel Therapeutic Target for Tissue Fibrosis

Annals of Translational Medicine
Medicine
2016English

GPR35 as a Novel Therapeutic Target

Frontiers in Endocrinology
EndocrinologyMetabolismDiabetes
2011English

Ceramide in Cystic Fibrosis: A Potential New Target for Therapeutic Intervention

Journal of Lipids
Biochemistry
2011English

Ion Channel Remodeling in Vascular Smooth Muscle During Hypertension: Implications for Novel Therapeutic Approaches

Pharmacological Research
Pharmacology
2013English

Novel Inhibitors of the Calcium-Activated K+ Channel KCa3.1 to Treat Non-Alcoholic Fatty Liver Disease and Liver Fibrosis

Biophysical Journal
Biophysics
2019English

AMPD1: A Novel Therapeutic Target for Reversing Insulin Resistance

BMC Endocrine Disorders
MedicineEndocrinologyMetabolismDiabetes
2014English

Ivacaftor: A Novel Gene-Based Therapeutic Approach for Cystic Fibrosis

Journal of Pediatric Pharmacology and Therapeutics
Child HealthPediatricsPerinatologyPharmacology
2013English

Mineralocorticoid Receptor Signaling as a Therapeutic Target for Renal and Cardiac Fibrosis

Frontiers in Pharmacology
Pharmacology
2017English

Abnormal Mitochondrial Dynamics—A Novel Therapeutic Target for Alzheimer's Disease?

Molecular Neurobiology
NeuroscienceNeurologyCellularMolecular Neuroscience
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy